시장보고서
상품코드
1839190

세계의 백신 보조제 시장 : 분석 및 예측(-2034년) : 유형, 제품, 용도, 기술, 최종 사용자, 프로세스, 성분, 단계, 기능

Vaccine Adjuvant Market Analysis and Forecast to 2034: Type, Product, Application, Technology, End User, Process, Component, Stage, Functionality

발행일: | 리서치사: Global Insight Services | 페이지 정보: 영문 320 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 백신 보조제 시장은 2024년 14억 달러에서 2034년까지 25억 달러로 확대되어 CAGR 약 6%를 보일 것으로 예측됩니다. 백신 보조제 시장은 백신에 대한 면역 반응을 높이는 약제를 포함하며 효과적인 예방 접종 개발에 필수적입니다. 이 보조제는 항원 특이적인 면역 반응을 강화하고 백신의 효능과 수명을 향상시킵니다. 감염증 유행 증가와 백신 기술의 진보가 시장 성장을 뒷받침하고 있습니다. 주요 동향은 신규 보조제 제제와 개별화 백신에 대한 주목 증가가 세계의 다양한 건강 과제에 대응하고 있습니다.

백신 보조제 시장은 면역학의 진보와 효과적인 백신에 대한 수요 증가에 힘입어 견조한 확대를 계속하고 있습니다. 병원체 성분을 기반으로 한 보조제 분야는 면역 반응의 특이성을 높이는 능력으로 최상위 자리를 차지합니다. 알루미늄염은 여전히 기존 보조제의 핵심이며, 확립된 안전성 프로파일을 통해 그 관련성을 유지하고 있습니다. 오일 에멀젼 보조제 부문은 강력하고 장기간 지속되는 면역 유도의 효능으로 두 번째로 높은 성과를 거두었습니다. 하위 부문 중에서 리포좀 기반 보조제는 기세를 증가시키고 있어, 이는 항원 전달 및 면역원성 향상에서의 다용도를 반영합니다. 사포닌 기반 보조제도 강력한 면역 자극 효과에 의해 관심이 높아지고 있습니다. 개인화 백신에 대한 관심 증가는 개별 면역 반응에 맞는 보조제 제제의 기술 혁신을 촉진합니다. 생명공학기업과 연구기관 간의 전략적 제휴로 차세대 보조제 개발이 가속화되고 있습니다. 안전과 효능의 중시가 계속 연구 활동의 원동력이 되어 시장의 지속적인 성장을 확실히 하고 있습니다.

시장 세분화
유형 알루미늄염, 오일 에멀젼, 리포좀, 사포닌, 중합체 보조제, 박테리아 유도체, 비로좀, 핵산 기반 보조제
제품 보조제 시스템, 독립 보조제, 콤비네이션 보조제
용도 감염, 암, 알레르기, 자가 면역 질환
기술 재조합 기술, 합성 기술, 컨쥬게이션 기술
최종 사용자 제약회사, 생명공학기업, 연구기관, 위탁연구기관
프로세스 제형화, 제조, 품질 관리
성분 유효성분, 안정제, 보존제, 계면활성제
단계 전임상, 임상시험, 상품화
기능 면역 강화, 항원 제시, 표적 전달

시장 현황

백신 보조제 시장은 신규 진출기업이 혁신적인 제품을 투입하는 한편 기존 기업이 강력한 포지션을 유지하고 시장 점유율이 역동적으로 변화하고 있습니다. 가격 전략은 진화하고 있으며 비용 효율성과 높은 효율성의 복잡한 균형을 반영합니다. 최근 제품 출시는 면역반응을 증강하고 부작용을 최소화하는 보다 표적화된 개별화 보조제 제제의 동향을 나타내고 있습니다. 이 시장은 신규 보조제의 지속적인 유입을 특징으로 하며, 이러한 보조제는 신흥 감염증에 대한 대응과 백신의 효능 향상에 매우 중요합니다. 백신 보조제 시장의 경쟁은 치열하고 주요 기업이 기술적 이점과 시장 지배력을 다투고 있습니다. 특히 북미와 유럽에서는 규제의 영향이 크고 엄격한 기준이 제품 개발과 승인 프로세스를 규정하고 있습니다. 각 회사는 이러한 규제 요구 사항을 충족하고 보조제 제제를 혁신하기 위해 연구 개발에 많은 투자를하고 있습니다. 시장은 또한 첨단 보조제에 대한 수요를 촉진하는 세계 보건 활동과 자금 조달의 영향을 받고 있습니다. 상황이 발전함에 따라 전략적 파트너십과 공동 연구는 경쟁 우위를 유지하는 데 매우 중요해지고 있습니다.

주요 동향 및 촉진요인:

백신 보조제 시장은 기술의 진보와 백신 수요 증가로 강력한 성장을 이루고 있습니다. 세계 감염 증가는 더욱 효과적인 백신의 필요성을 증가시키고 보조제 개발을 촉진하고 있습니다. 주요 동향은 백신의 효능과 안전성을 향상시키는 신규 보조제 기술의 통합을 포함합니다. 개인화된 의료 수요도 보조 연구에 영향을 미치고 있으며 맞춤형 면역 반응에 중점을 둡니다. 규제 당국의 지원과 신속한 승인 과정은 시장 확대를 더욱 촉진하고 있습니다. 보조제 제제를 혁신하기 위해 제약 회사의 R&D 투자가 점점 더 중요해지고 있습니다. 또한 바이오테크놀러지 기업과 연구기관의 제휴와 공동 연구가 신제품 개발을 촉진하고 있습니다. 신흥 시장은 건강 관리 인프라와 예방 접종 프로그램 증가로 유리한 비즈니스 기회를 제공합니다. 이러한 지역에서는 미충족 의료 수요에 대한 대응이 중시되어 시장 성장의 원동력이 되고 있습니다. 지속적인 혁신과 전략적 제휴로 백신 보조제 시장은 지속적인 확대가 예상됩니다.

억제요인과 도전:

백신 보조제 시장은 현재 몇 가지 심각한 억제요인과 문제에 직면하고 있습니다. 주요 과제 중 하나는 규제 상황의 엄격함입니다. 규제 기관은 엄격한 기준을 부과하므로 제품 승인이 지연되고 개발 비용이 증가할 수 있습니다. 따라서 중소기업 시장 진입이 방해될 수 있습니다. 또한, 의료 종사자와 일반 시민들 사이에서 보조제에 대한 인식과 이해가 부족합니다. 이 때문에 보조제를 포함한 백신을 채용하는 것에 저항감이나 주저함이 생겨 시장 침투에 영향을 미칠 가능성이 있습니다. 또한, 보조제 제형은 복잡하기 때문에 기술적 과제도 있습니다. 안정적이고 효과적인 조합을 개발하려면 첨단 기술과 전문 지식이 필요하며 모든 기업이 이를 가지고 있는 것은 아닙니다. 공급망의 혼란도 도전 중 하나입니다. 세계 사건과 지정학적 긴장은 원재료 입수에 영향을 미칠 수 있으며 생산 일정과 비용에 영향을 줄 수 있습니다. 마지막으로 치열한 경쟁이 있습니다. 기존 기업이 시장을 독점하고 있기 때문에 신규 진출기업이 발판을 굳히는 것은 어렵습니다. 이러한 요인은 백신 보조제 시장의 성장성을 제한합니다.

주요 기업

Seppic, Croda International, Avanti Polar Lipids, Aphios Corporation, Vaxine Pty Ltd, Brenntag Biosector, Adjuvatis, MVP Laboratories, Creative Biolabs, OZ Biosciences, InvivoGen, GSK Vaccines Institute for Global Health, Dynavax Technologies, Novavax, EpiVax

목차

제1장 백신 보조제 시장 개요

  • 조사 목적
  • 백신 보조제 시장 정의와 조사 범위
  • 보고서의 제한 사항
  • 조사 대상 연도 및 통화
  • 조사 방법

제2장 주요 요약

제3장 시장에 관한 중요 인사이트

제4장 백신 보조제 시장 전망

  • 백신 보조제 시장의 세분화
  • 시장 역학
  • Porter's Five Forces 분석
  • PESTLE 분석
  • 밸류체인 분석
  • 4P 모델
  • ANSOFF 매트릭스

제5장 백신 보조제 시장 전략

  • 상위 시장 분석
  • 수급 분석
  • 소비자의 구매 의욕
  • 사례 연구 분석
  • 가격 분석
  • 규제 상황
  • 공급망 분석
  • 경쟁 제품 분석
  • 최근 동향

제6장 백신 보조제 시장 규모

  • 백신 보조제 시장 규모 : 금액별
  • 백신 보조제 시장 규모 : 수량별

제7장 백신 보조제 시장 : 유형별

  • 시장 개요
  • 알루미늄염
  • 오일 에멀젼
  • 리포솜
  • 사포닌
  • 고분자 보조제
  • 박테리아 유도체
  • 비로좀
  • 핵산 보조제
  • 기타

제8장 백신 보조제 시장 : 제품별

  • 시장 개요
  • 보조제 시스템
  • 독립 보조제
  • 콤비네이션 보조제
  • 기타

제9장 백신 보조제 시장 : 용도별

  • 시장 개요
  • 감염증
  • 알레르기
  • 자가면역질환
  • 기타

제10장 백신 보조제 시장 : 기술별

  • 시장 개요
  • 재조합 기술
  • 합성 기술
  • 컨쥬게이션 기술
  • 기타

제11장 백신 보조제 시장 : 최종 사용자별

  • 시장 개요
  • 제약기업
  • 바이오테크놀러지 기업
  • 연구기관
  • 수탁연구기관
  • 기타

제12장 백신 보조제 시장 : 프로세스별

  • 시장 개요
  • 제제화
  • 제조
  • 품질관리
  • 기타

제13장 백신 보조제 시장 : 성분별

  • 시장 개요
  • 유효성분
  • 안정제
  • 방부제
  • 계면활성제
  • 기타

제14장 백신 보조제 시장 : 단계별

  • 시장 개요
  • 전임상
  • 임상시험
  • 상업화
  • 기타

제15장 백신 보조제 시장 : 기능별

  • 시장 개요
  • 면역 강화
  • 항원 제시
  • 표적 전달
  • 기타

제16장 백신 보조제 시장 : 지역별

  • 개요
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 스페인
    • 이탈리아
    • 네덜란드
    • 스웨덴
    • 스위스
    • 덴마크
    • 핀란드
    • 러시아
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주
    • 싱가포르
    • 인도네시아
    • 대만
    • 말레이시아
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 멕시코
    • 아르헨티나
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 남아프리카
    • 기타 중동 및 아프리카

제17장 경쟁 구도

  • 개요
  • 시장 점유율 분석
  • 주요 기업의 포지셔닝
  • 경쟁 리더십 매핑
  • 벤더 벤치마킹
  • 개발 전략의 벤치마킹

제18장 기업 프로파일

  • Seppic
  • Croda International
  • Avanti Polar Lipids
  • Aphios Corporation
  • Vaxine Pty Ltd
  • Brenntag Biosector
  • Adjuvatis
  • MVP Laboratories
  • Creative Biolabs
  • OZ Biosciences
  • InvivoGen
  • GSK Vaccines Institute for Global Health
  • Dynavax Technologies
  • Novavax
  • EpiVax
JHS

Vaccine Adjuvant Market is anticipated to expand from $1.4 billion in 2024 to $2.5 billion by 2034, growing at a CAGR of approximately 6%. The Vaccine Adjuvant Market encompasses agents enhancing the immune response to vaccines, crucial in developing effective immunizations. These adjuvants bolster antigen-specific immune reactions, improving vaccine efficacy and longevity. Rising infectious disease prevalence and advancements in vaccine technology propel market growth. Key trends include novel adjuvant formulations and increased focus on personalized vaccines, addressing diverse global health challenges.

The Vaccine Adjuvant Market is experiencing robust expansion, fueled by advancements in immunology and rising demand for effective vaccines. The pathogen component-based adjuvant segment is the top performer, driven by its ability to enhance immune response specificity. Aluminum salts remain a cornerstone in traditional adjuvants, maintaining their relevance due to established safety profiles. The oil emulsion adjuvants segment is the second-highest performer, benefiting from their efficacy in inducing strong and long-lasting immunity. Among sub-segments, the liposome-based adjuvants are gaining momentum, reflecting their versatility in delivering antigens and boosting immunogenicity. Saponin-based adjuvants are also witnessing increased interest for their potent immunostimulatory effects. The growing focus on personalized vaccines is fostering innovation in adjuvant formulations, tailored to individual immune responses. Strategic collaborations between biotech firms and research institutions are accelerating the development of next-generation adjuvants. The emphasis on safety and efficacy continues to drive research efforts, ensuring sustained market growth.

Market Segmentation
TypeAluminum Salts, Oil Emulsions, Liposomes, Saponins, Polymer Adjuvants, Bacterial Derivatives, Virosomes, Nucleic Acid-based Adjuvants
ProductAdjuvant Systems, Stand-alone Adjuvants, Combination Adjuvants
ApplicationInfectious Diseases, Cancer, Allergies, Autoimmune Disorders
TechnologyRecombinant Technology, Synthetic Technology, Conjugation Technology
End UserPharmaceutical Companies, Biotechnology Companies, Research Institutes, Contract Research Organizations
ProcessFormulation, Manufacturing, Quality Control
ComponentActive Ingredients, Stabilizers, Preservatives, Surfactants
StagePreclinical, Clinical Trials, Commercialization
FunctionalityImmune Enhancement, Antigen Presentation, Targeted Delivery

Market Snapshot:

The Vaccine Adjuvant Market is witnessing a dynamic shift in market share, with established players maintaining strong positions while new entrants introduce innovative products. Pricing strategies are evolving, reflecting the intricate balance between cost-effectiveness and high efficacy. Recent product launches demonstrate a trend toward more targeted and personalized adjuvant formulations, enhancing immune responses and minimizing adverse effects. The market is characterized by a continuous influx of novel adjuvants, which are pivotal in addressing emerging infectious diseases and improving vaccine efficacy. Competition in the Vaccine Adjuvant Market is intense, with key players vying for technological superiority and market dominance. Regulatory influences are profound, particularly in North America and Europe, where stringent standards dictate product development and approval processes. Companies are investing heavily in research and development to meet these regulatory demands and to innovate in adjuvant formulations. The market is also influenced by global health initiatives and funding, which drive demand for advanced adjuvants. As the landscape evolves, strategic partnerships and collaborations are becoming crucial for sustaining competitive advantage.

Geographical Overview:

The vaccine adjuvant market demonstrates varied dynamics across global regions. North America leads, driven by robust healthcare infrastructure and significant R&D investments. The region's focus on innovative vaccine development enhances its market position. Europe follows closely, with strong government support and an emphasis on biopharmaceutical research fostering growth. Asia Pacific emerges as a promising region, with rapid advancements in biotechnology and increasing healthcare expenditures. Countries like China and India are at the forefront, investing heavily in vaccine production capabilities. Latin America and the Middle East & Africa are also gaining traction. In Latin America, Brazil and Mexico are notable for their expanding pharmaceutical sectors. In the Middle East & Africa, increasing awareness and government initiatives to improve healthcare access are key growth drivers. These regions offer lucrative opportunities for market players aiming to expand their global footprint. The diverse regional dynamics underscore the market's potential for sustained growth and innovation.

Key Trends and Drivers:

The Vaccine Adjuvant Market is experiencing robust growth driven by technological advancements and increased vaccine demand. Rising incidences of infectious diseases globally are propelling the need for more effective vaccines, thus boosting adjuvant development. Key trends include the integration of novel adjuvant technologies enhancing vaccine efficacy and safety. The demand for personalized medicine is also influencing adjuvant research, with a focus on tailored immune responses. Regulatory support and expedited approval processes are further catalyzing market expansion. There is an increasing emphasis on research and development investments by pharmaceutical companies to innovate adjuvant formulations. Additionally, partnerships and collaborations between biotech firms and research institutions are fostering new product development. Emerging markets present lucrative opportunities due to increasing healthcare infrastructure and immunization programs. The focus on addressing unmet medical needs in these regions is driving market growth. With continuous innovation and strategic alliances, the Vaccine Adjuvant Market is poised for sustained expansion.

Restraints and Challenges:

The vaccine adjuvant market currently faces several significant restraints and challenges. One primary challenge is the stringent regulatory landscape. Regulatory bodies impose rigorous standards, which can delay product approvals and increase development costs. This can deter smaller companies from entering the market. Moreover, there is a lack of awareness and understanding of adjuvants among healthcare professionals and the public. This can lead to resistance or hesitation in adopting vaccines that include adjuvants, impacting market penetration. Additionally, the complexity of adjuvant formulations presents technical challenges. Developing stable, effective combinations requires advanced technology and expertise, which not all companies possess. Supply chain disruptions pose another challenge. Global events and geopolitical tensions can impact the availability of raw materials, affecting production timelines and costs. Lastly, there is intense competition. Established players dominate the market, making it difficult for new entrants to gain a foothold. These factors collectively constrain the growth potential of the vaccine adjuvant market.

Key Players:

Seppic, Croda International, Avanti Polar Lipids, Aphios Corporation, Vaxine Pty Ltd, Brenntag Biosector, Adjuvatis, MVP Laboratories, Creative Biolabs, OZ Biosciences, InvivoGen, GSK Vaccines Institute for Global Health, Dynavax Technologies, Novavax, EpiVax

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Vaccine Adjuvant Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Vaccine Adjuvant Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Application
  • 2.6 Key Highlights of the Market, by Technology
  • 2.7 Key Highlights of the Market, by End User
  • 2.8 Key Highlights of the Market, by Process
  • 2.9 Key Highlights of the Market, by Component
  • 2.10 Key Highlights of the Market, by Stage
  • 2.11 Key Highlights of the Market, by Functionality
  • 2.12 Key Highlights of the Market, by North America
  • 2.13 Key Highlights of the Market, by Europe
  • 2.14 Key Highlights of the Market, by Asia-Pacific
  • 2.15 Key Highlights of the Market, by Latin America
  • 2.16 Key Highlights of the Market, by Middle East
  • 2.17 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Application
  • 3.5 Market Attractiveness Analysis, by Technology
  • 3.6 Market Attractiveness Analysis, by End User
  • 3.7 Market Attractiveness Analysis, by Process
  • 3.8 Market Attractiveness Analysis, by Component
  • 3.9 Market Attractiveness Analysis, by Stage
  • 3.10 Market Attractiveness Analysis, by Functionality
  • 3.11 Market Attractiveness Analysis, by North America
  • 3.12 Market Attractiveness Analysis, by Europe
  • 3.13 Market Attractiveness Analysis, by Asia-Pacific
  • 3.14 Market Attractiveness Analysis, by Latin America
  • 3.15 Market Attractiveness Analysis, by Middle East
  • 3.16 Market Attractiveness Analysis, by Africa

4: Vaccine Adjuvant Market Outlook

  • 4.1 Vaccine Adjuvant Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Vaccine Adjuvant Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Vaccine Adjuvant Market Size

  • 6.1 Vaccine Adjuvant Market Size, by Value
  • 6.2 Vaccine Adjuvant Market Size, by Volume

7: Vaccine Adjuvant Market, by Type

  • 7.1 Market Overview
  • 7.2 Aluminum Salts
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Oil Emulsions
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Liposomes
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Saponins
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region
  • 7.6 Polymer Adjuvants
    • 7.6.1 Key Market Trends & Opportunity Analysis
    • 7.6.2 Market Size and Forecast, by Region
  • 7.7 Bacterial Derivatives
    • 7.7.1 Key Market Trends & Opportunity Analysis
    • 7.7.2 Market Size and Forecast, by Region
  • 7.8 Virosomes
    • 7.8.1 Key Market Trends & Opportunity Analysis
    • 7.8.2 Market Size and Forecast, by Region
  • 7.9 Nucleic Acid-based Adjuvants
    • 7.9.1 Key Market Trends & Opportunity Analysis
    • 7.9.2 Market Size and Forecast, by Region
  • 7.10 Others
    • 7.10.1 Key Market Trends & Opportunity Analysis
    • 7.10.2 Market Size and Forecast, by Region

8: Vaccine Adjuvant Market, by Product

  • 8.1 Market Overview
  • 8.2 Adjuvant Systems
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Stand-alone Adjuvants
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Combination Adjuvants
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Others
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region

9: Vaccine Adjuvant Market, by Application

  • 9.1 Market Overview
  • 9.2 Infectious Diseases
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Cancer
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Allergies
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Autoimmune Disorders
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region
  • 9.6 Others
    • 9.6.1 Key Market Trends & Opportunity Analysis
    • 9.6.2 Market Size and Forecast, by Region

10: Vaccine Adjuvant Market, by Technology

  • 10.1 Market Overview
  • 10.2 Recombinant Technology
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Synthetic Technology
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Conjugation Technology
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Others
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region

11: Vaccine Adjuvant Market, by End User

  • 11.1 Market Overview
  • 11.2 Pharmaceutical Companies
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Biotechnology Companies
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Research Institutes
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Contract Research Organizations
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region
  • 11.6 Others
    • 11.6.1 Key Market Trends & Opportunity Analysis
    • 11.6.2 Market Size and Forecast, by Region

12: Vaccine Adjuvant Market, by Process

  • 12.1 Market Overview
  • 12.2 Formulation
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Manufacturing
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Quality Control
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Others
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region

13: Vaccine Adjuvant Market, by Component

  • 13.1 Market Overview
  • 13.2 Active Ingredients
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Stabilizers
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Preservatives
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region
  • 13.5 Surfactants
    • 13.5.1 Key Market Trends & Opportunity Analysis
    • 13.5.2 Market Size and Forecast, by Region
  • 13.6 Others
    • 13.6.1 Key Market Trends & Opportunity Analysis
    • 13.6.2 Market Size and Forecast, by Region

14: Vaccine Adjuvant Market, by Stage

  • 14.1 Market Overview
  • 14.2 Preclinical
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Clinical Trials
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Commercialization
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region
  • 14.5 Others
    • 14.5.1 Key Market Trends & Opportunity Analysis
    • 14.5.2 Market Size and Forecast, by Region

15: Vaccine Adjuvant Market, by Functionality

  • 15.1 Market Overview
  • 15.2 Immune Enhancement
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Antigen Presentation
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Targeted Delivery
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region
  • 15.5 Others
    • 15.5.1 Key Market Trends & Opportunity Analysis
    • 15.5.2 Market Size and Forecast, by Region

16: Vaccine Adjuvant Market, by Region

  • 16.1 Overview
  • 16.2 North America
    • 16.2.1 Key Market Trends and Opportunities
    • 16.2.2 North America Market Size and Forecast, by Type
    • 16.2.3 North America Market Size and Forecast, by Product
    • 16.2.4 North America Market Size and Forecast, by Application
    • 16.2.5 North America Market Size and Forecast, by Technology
    • 16.2.6 North America Market Size and Forecast, by End User
    • 16.2.7 North America Market Size and Forecast, by Process
    • 16.2.8 North America Market Size and Forecast, by Component
    • 16.2.9 North America Market Size and Forecast, by Stage
    • 16.2.10 North America Market Size and Forecast, by Functionality
    • 16.2.11 North America Market Size and Forecast, by Country
    • 16.2.12 United States
      • 16.2.9.1 United States Market Size and Forecast, by Type
      • 16.2.9.2 United States Market Size and Forecast, by Product
      • 16.2.9.3 United States Market Size and Forecast, by Application
      • 16.2.9.4 United States Market Size and Forecast, by Technology
      • 16.2.9.5 United States Market Size and Forecast, by End User
      • 16.2.9.6 United States Market Size and Forecast, by Process
      • 16.2.9.7 United States Market Size and Forecast, by Component
      • 16.2.9.8 United States Market Size and Forecast, by Stage
      • 16.2.9.9 United States Market Size and Forecast, by Functionality
      • 16.2.9.10 Local Competition Analysis
      • 16.2.9.11 Local Market Analysis
    • 16.2.1 Canada
      • 16.2.10.1 Canada Market Size and Forecast, by Type
      • 16.2.10.2 Canada Market Size and Forecast, by Product
      • 16.2.10.3 Canada Market Size and Forecast, by Application
      • 16.2.10.4 Canada Market Size and Forecast, by Technology
      • 16.2.10.5 Canada Market Size and Forecast, by End User
      • 16.2.10.6 Canada Market Size and Forecast, by Process
      • 16.2.10.7 Canada Market Size and Forecast, by Component
      • 16.2.10.8 Canada Market Size and Forecast, by Stage
      • 16.2.10.9 Canada Market Size and Forecast, by Functionality
      • 16.2.10.10 Local Competition Analysis
      • 16.2.10.11 Local Market Analysis
  • 16.1 Europe
    • 16.3.1 Key Market Trends and Opportunities
    • 16.3.2 Europe Market Size and Forecast, by Type
    • 16.3.3 Europe Market Size and Forecast, by Product
    • 16.3.4 Europe Market Size and Forecast, by Application
    • 16.3.5 Europe Market Size and Forecast, by Technology
    • 16.3.6 Europe Market Size and Forecast, by End User
    • 16.3.7 Europe Market Size and Forecast, by Process
    • 16.3.8 Europe Market Size and Forecast, by Component
    • 16.3.9 Europe Market Size and Forecast, by Stage
    • 16.3.10 Europe Market Size and Forecast, by Functionality
    • 16.3.11 Europe Market Size and Forecast, by Country
    • 16.3.12 United Kingdom
      • 16.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 16.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 16.3.9.3 United Kingdom Market Size and Forecast, by Application
      • 16.3.9.4 United Kingdom Market Size and Forecast, by Technology
      • 16.3.9.5 United Kingdom Market Size and Forecast, by End User
      • 16.3.9.6 United Kingdom Market Size and Forecast, by Process
      • 16.3.9.7 United Kingdom Market Size and Forecast, by Component
      • 16.3.9.8 United Kingdom Market Size and Forecast, by Stage
      • 16.3.9.9 United Kingdom Market Size and Forecast, by Functionality
      • 16.3.9.10 Local Competition Analysis
      • 16.3.9.11 Local Market Analysis
    • 16.3.1 Germany
      • 16.3.10.1 Germany Market Size and Forecast, by Type
      • 16.3.10.2 Germany Market Size and Forecast, by Product
      • 16.3.10.3 Germany Market Size and Forecast, by Application
      • 16.3.10.4 Germany Market Size and Forecast, by Technology
      • 16.3.10.5 Germany Market Size and Forecast, by End User
      • 16.3.10.6 Germany Market Size and Forecast, by Process
      • 16.3.10.7 Germany Market Size and Forecast, by Component
      • 16.3.10.8 Germany Market Size and Forecast, by Stage
      • 16.3.10.9 Germany Market Size and Forecast, by Functionality
      • 16.3.10.10 Local Competition Analysis
      • 16.3.10.11 Local Market Analysis
    • 16.3.1 France
      • 16.3.11.1 France Market Size and Forecast, by Type
      • 16.3.11.2 France Market Size and Forecast, by Product
      • 16.3.11.3 France Market Size and Forecast, by Application
      • 16.3.11.4 France Market Size and Forecast, by Technology
      • 16.3.11.5 France Market Size and Forecast, by End User
      • 16.3.11.6 France Market Size and Forecast, by Process
      • 16.3.11.7 France Market Size and Forecast, by Component
      • 16.3.11.8 France Market Size and Forecast, by Stage
      • 16.3.11.9 France Market Size and Forecast, by Functionality
      • 16.3.11.10 Local Competition Analysis
      • 16.3.11.11 Local Market Analysis
    • 16.3.1 Spain
      • 16.3.12.1 Spain Market Size and Forecast, by Type
      • 16.3.12.2 Spain Market Size and Forecast, by Product
      • 16.3.12.3 Spain Market Size and Forecast, by Application
      • 16.3.12.4 Spain Market Size and Forecast, by Technology
      • 16.3.12.5 Spain Market Size and Forecast, by End User
      • 16.3.12.6 Spain Market Size and Forecast, by Process
      • 16.3.12.7 Spain Market Size and Forecast, by Component
      • 16.3.12.8 Spain Market Size and Forecast, by Stage
      • 16.3.12.9 Spain Market Size and Forecast, by Functionality
      • 16.3.12.10 Local Competition Analysis
      • 16.3.12.11 Local Market Analysis
    • 16.3.1 Italy
      • 16.3.13.1 Italy Market Size and Forecast, by Type
      • 16.3.13.2 Italy Market Size and Forecast, by Product
      • 16.3.13.3 Italy Market Size and Forecast, by Application
      • 16.3.13.4 Italy Market Size and Forecast, by Technology
      • 16.3.13.5 Italy Market Size and Forecast, by End User
      • 16.3.13.6 Italy Market Size and Forecast, by Process
      • 16.3.13.7 Italy Market Size and Forecast, by Component
      • 16.3.13.8 Italy Market Size and Forecast, by Stage
      • 16.3.13.9 Italy Market Size and Forecast, by Functionality
      • 16.3.13.10 Local Competition Analysis
      • 16.3.13.11 Local Market Analysis
    • 16.3.1 Netherlands
      • 16.3.14.1 Netherlands Market Size and Forecast, by Type
      • 16.3.14.2 Netherlands Market Size and Forecast, by Product
      • 16.3.14.3 Netherlands Market Size and Forecast, by Application
      • 16.3.14.4 Netherlands Market Size and Forecast, by Technology
      • 16.3.14.5 Netherlands Market Size and Forecast, by End User
      • 16.3.14.6 Netherlands Market Size and Forecast, by Process
      • 16.3.14.7 Netherlands Market Size and Forecast, by Component
      • 16.3.14.8 Netherlands Market Size and Forecast, by Stage
      • 16.3.14.9 Netherlands Market Size and Forecast, by Functionality
      • 16.3.14.10 Local Competition Analysis
      • 16.3.14.11 Local Market Analysis
    • 16.3.1 Sweden
      • 16.3.15.1 Sweden Market Size and Forecast, by Type
      • 16.3.15.2 Sweden Market Size and Forecast, by Product
      • 16.3.15.3 Sweden Market Size and Forecast, by Application
      • 16.3.15.4 Sweden Market Size and Forecast, by Technology
      • 16.3.15.5 Sweden Market Size and Forecast, by End User
      • 16.3.15.6 Sweden Market Size and Forecast, by Process
      • 16.3.15.7 Sweden Market Size and Forecast, by Component
      • 16.3.15.8 Sweden Market Size and Forecast, by Stage
      • 16.3.15.9 Sweden Market Size and Forecast, by Functionality
      • 16.3.15.10 Local Competition Analysis
      • 16.3.15.11 Local Market Analysis
    • 16.3.1 Switzerland
      • 16.3.16.1 Switzerland Market Size and Forecast, by Type
      • 16.3.16.2 Switzerland Market Size and Forecast, by Product
      • 16.3.16.3 Switzerland Market Size and Forecast, by Application
      • 16.3.16.4 Switzerland Market Size and Forecast, by Technology
      • 16.3.16.5 Switzerland Market Size and Forecast, by End User
      • 16.3.16.6 Switzerland Market Size and Forecast, by Process
      • 16.3.16.7 Switzerland Market Size and Forecast, by Component
      • 16.3.16.8 Switzerland Market Size and Forecast, by Stage
      • 16.3.16.9 Switzerland Market Size and Forecast, by Functionality
      • 16.3.16.10 Local Competition Analysis
      • 16.3.16.11 Local Market Analysis
    • 16.3.1 Denmark
      • 16.3.17.1 Denmark Market Size and Forecast, by Type
      • 16.3.17.2 Denmark Market Size and Forecast, by Product
      • 16.3.17.3 Denmark Market Size and Forecast, by Application
      • 16.3.17.4 Denmark Market Size and Forecast, by Technology
      • 16.3.17.5 Denmark Market Size and Forecast, by End User
      • 16.3.17.6 Denmark Market Size and Forecast, by Process
      • 16.3.17.7 Denmark Market Size and Forecast, by Component
      • 16.3.17.8 Denmark Market Size and Forecast, by Stage
      • 16.3.17.9 Denmark Market Size and Forecast, by Functionality
      • 16.3.17.10 Local Competition Analysis
      • 16.3.17.11 Local Market Analysis
    • 16.3.1 Finland
      • 16.3.18.1 Finland Market Size and Forecast, by Type
      • 16.3.18.2 Finland Market Size and Forecast, by Product
      • 16.3.18.3 Finland Market Size and Forecast, by Application
      • 16.3.18.4 Finland Market Size and Forecast, by Technology
      • 16.3.18.5 Finland Market Size and Forecast, by End User
      • 16.3.18.6 Finland Market Size and Forecast, by Process
      • 16.3.18.7 Finland Market Size and Forecast, by Component
      • 16.3.18.8 Finland Market Size and Forecast, by Stage
      • 16.3.18.9 Finland Market Size and Forecast, by Functionality
      • 16.3.18.10 Local Competition Analysis
      • 16.3.18.11 Local Market Analysis
    • 16.3.1 Russia
      • 16.3.19.1 Russia Market Size and Forecast, by Type
      • 16.3.19.2 Russia Market Size and Forecast, by Product
      • 16.3.19.3 Russia Market Size and Forecast, by Application
      • 16.3.19.4 Russia Market Size and Forecast, by Technology
      • 16.3.19.5 Russia Market Size and Forecast, by End User
      • 16.3.19.6 Russia Market Size and Forecast, by Process
      • 16.3.19.7 Russia Market Size and Forecast, by Component
      • 16.3.19.8 Russia Market Size and Forecast, by Stage
      • 16.3.19.9 Russia Market Size and Forecast, by Functionality
      • 16.3.19.10 Local Competition Analysis
      • 16.3.19.11 Local Market Analysis
    • 16.3.1 Rest of Europe
      • 16.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 16.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 16.3.20.3 Rest of Europe Market Size and Forecast, by Application
      • 16.3.20.4 Rest of Europe Market Size and Forecast, by Technology
      • 16.3.20.5 Rest of Europe Market Size and Forecast, by End User
      • 16.3.20.6 Rest of Europe Market Size and Forecast, by Process
      • 16.3.20.7 Rest of Europe Market Size and Forecast, by Component
      • 16.3.20.8 Rest of Europe Market Size and Forecast, by Stage
      • 16.3.20.9 Rest of Europe Market Size and Forecast, by Functionality
      • 16.3.20.10 Local Competition Analysis
      • 16.3.20.11 Local Market Analysis
  • 16.1 Asia-Pacific
    • 16.4.1 Key Market Trends and Opportunities
    • 16.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 16.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 16.4.4 Asia-Pacific Market Size and Forecast, by Application
    • 16.4.5 Asia-Pacific Market Size and Forecast, by Technology
    • 16.4.6 Asia-Pacific Market Size and Forecast, by End User
    • 16.4.7 Asia-Pacific Market Size and Forecast, by Process
    • 16.4.8 Asia-Pacific Market Size and Forecast, by Component
    • 16.4.9 Asia-Pacific Market Size and Forecast, by Stage
    • 16.4.10 Asia-Pacific Market Size and Forecast, by Functionality
    • 16.4.11 Asia-Pacific Market Size and Forecast, by Country
    • 16.4.12 China
      • 16.4.9.1 China Market Size and Forecast, by Type
      • 16.4.9.2 China Market Size and Forecast, by Product
      • 16.4.9.3 China Market Size and Forecast, by Application
      • 16.4.9.4 China Market Size and Forecast, by Technology
      • 16.4.9.5 China Market Size and Forecast, by End User
      • 16.4.9.6 China Market Size and Forecast, by Process
      • 16.4.9.7 China Market Size and Forecast, by Component
      • 16.4.9.8 China Market Size and Forecast, by Stage
      • 16.4.9.9 China Market Size and Forecast, by Functionality
      • 16.4.9.10 Local Competition Analysis
      • 16.4.9.11 Local Market Analysis
    • 16.4.1 India
      • 16.4.10.1 India Market Size and Forecast, by Type
      • 16.4.10.2 India Market Size and Forecast, by Product
      • 16.4.10.3 India Market Size and Forecast, by Application
      • 16.4.10.4 India Market Size and Forecast, by Technology
      • 16.4.10.5 India Market Size and Forecast, by End User
      • 16.4.10.6 India Market Size and Forecast, by Process
      • 16.4.10.7 India Market Size and Forecast, by Component
      • 16.4.10.8 India Market Size and Forecast, by Stage
      • 16.4.10.9 India Market Size and Forecast, by Functionality
      • 16.4.10.10 Local Competition Analysis
      • 16.4.10.11 Local Market Analysis
    • 16.4.1 Japan
      • 16.4.11.1 Japan Market Size and Forecast, by Type
      • 16.4.11.2 Japan Market Size and Forecast, by Product
      • 16.4.11.3 Japan Market Size and Forecast, by Application
      • 16.4.11.4 Japan Market Size and Forecast, by Technology
      • 16.4.11.5 Japan Market Size and Forecast, by End User
      • 16.4.11.6 Japan Market Size and Forecast, by Process
      • 16.4.11.7 Japan Market Size and Forecast, by Component
      • 16.4.11.8 Japan Market Size and Forecast, by Stage
      • 16.4.11.9 Japan Market Size and Forecast, by Functionality
      • 16.4.11.10 Local Competition Analysis
      • 16.4.11.11 Local Market Analysis
    • 16.4.1 South Korea
      • 16.4.12.1 South Korea Market Size and Forecast, by Type
      • 16.4.12.2 South Korea Market Size and Forecast, by Product
      • 16.4.12.3 South Korea Market Size and Forecast, by Application
      • 16.4.12.4 South Korea Market Size and Forecast, by Technology
      • 16.4.12.5 South Korea Market Size and Forecast, by End User
      • 16.4.12.6 South Korea Market Size and Forecast, by Process
      • 16.4.12.7 South Korea Market Size and Forecast, by Component
      • 16.4.12.8 South Korea Market Size and Forecast, by Stage
      • 16.4.12.9 South Korea Market Size and Forecast, by Functionality
      • 16.4.12.10 Local Competition Analysis
      • 16.4.12.11 Local Market Analysis
    • 16.4.1 Australia
      • 16.4.13.1 Australia Market Size and Forecast, by Type
      • 16.4.13.2 Australia Market Size and Forecast, by Product
      • 16.4.13.3 Australia Market Size and Forecast, by Application
      • 16.4.13.4 Australia Market Size and Forecast, by Technology
      • 16.4.13.5 Australia Market Size and Forecast, by End User
      • 16.4.13.6 Australia Market Size and Forecast, by Process
      • 16.4.13.7 Australia Market Size and Forecast, by Component
      • 16.4.13.8 Australia Market Size and Forecast, by Stage
      • 16.4.13.9 Australia Market Size and Forecast, by Functionality
      • 16.4.13.10 Local Competition Analysis
      • 16.4.13.11 Local Market Analysis
    • 16.4.1 Singapore
      • 16.4.14.1 Singapore Market Size and Forecast, by Type
      • 16.4.14.2 Singapore Market Size and Forecast, by Product
      • 16.4.14.3 Singapore Market Size and Forecast, by Application
      • 16.4.14.4 Singapore Market Size and Forecast, by Technology
      • 16.4.14.5 Singapore Market Size and Forecast, by End User
      • 16.4.14.6 Singapore Market Size and Forecast, by Process
      • 16.4.14.7 Singapore Market Size and Forecast, by Component
      • 16.4.14.8 Singapore Market Size and Forecast, by Stage
      • 16.4.14.9 Singapore Market Size and Forecast, by Functionality
      • 16.4.14.10 Local Competition Analysis
      • 16.4.14.11 Local Market Analysis
    • 16.4.1 Indonesia
      • 16.4.15.1 Indonesia Market Size and Forecast, by Type
      • 16.4.15.2 Indonesia Market Size and Forecast, by Product
      • 16.4.15.3 Indonesia Market Size and Forecast, by Application
      • 16.4.15.4 Indonesia Market Size and Forecast, by Technology
      • 16.4.15.5 Indonesia Market Size and Forecast, by End User
      • 16.4.15.6 Indonesia Market Size and Forecast, by Process
      • 16.4.15.7 Indonesia Market Size and Forecast, by Component
      • 16.4.15.8 Indonesia Market Size and Forecast, by Stage
      • 16.4.15.9 Indonesia Market Size and Forecast, by Functionality
      • 16.4.15.10 Local Competition Analysis
      • 16.4.15.11 Local Market Analysis
    • 16.4.1 Taiwan
      • 16.4.16.1 Taiwan Market Size and Forecast, by Type
      • 16.4.16.2 Taiwan Market Size and Forecast, by Product
      • 16.4.16.3 Taiwan Market Size and Forecast, by Application
      • 16.4.16.4 Taiwan Market Size and Forecast, by Technology
      • 16.4.16.5 Taiwan Market Size and Forecast, by End User
      • 16.4.16.6 Taiwan Market Size and Forecast, by Process
      • 16.4.16.7 Taiwan Market Size and Forecast, by Component
      • 16.4.16.8 Taiwan Market Size and Forecast, by Stage
      • 16.4.16.9 Taiwan Market Size and Forecast, by Functionality
      • 16.4.16.10 Local Competition Analysis
      • 16.4.16.11 Local Market Analysis
    • 16.4.1 Malaysia
      • 16.4.17.1 Malaysia Market Size and Forecast, by Type
      • 16.4.17.2 Malaysia Market Size and Forecast, by Product
      • 16.4.17.3 Malaysia Market Size and Forecast, by Application
      • 16.4.17.4 Malaysia Market Size and Forecast, by Technology
      • 16.4.17.5 Malaysia Market Size and Forecast, by End User
      • 16.4.17.6 Malaysia Market Size and Forecast, by Process
      • 16.4.17.7 Malaysia Market Size and Forecast, by Component
      • 16.4.17.8 Malaysia Market Size and Forecast, by Stage
      • 16.4.17.9 Malaysia Market Size and Forecast, by Functionality
      • 16.4.17.10 Local Competition Analysis
      • 16.4.17.11 Local Market Analysis
    • 16.4.1 Rest of Asia-Pacific
      • 16.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 16.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 16.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 16.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 16.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 16.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by Process
      • 16.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Component
      • 16.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Stage
      • 16.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Functionality
      • 16.4.18.10 Local Competition Analysis
      • 16.4.18.11 Local Market Analysis
  • 16.1 Latin America
    • 16.5.1 Key Market Trends and Opportunities
    • 16.5.2 Latin America Market Size and Forecast, by Type
    • 16.5.3 Latin America Market Size and Forecast, by Product
    • 16.5.4 Latin America Market Size and Forecast, by Application
    • 16.5.5 Latin America Market Size and Forecast, by Technology
    • 16.5.6 Latin America Market Size and Forecast, by End User
    • 16.5.7 Latin America Market Size and Forecast, by Process
    • 16.5.8 Latin America Market Size and Forecast, by Component
    • 16.5.9 Latin America Market Size and Forecast, by Stage
    • 16.5.10 Latin America Market Size and Forecast, by Functionality
    • 16.5.11 Latin America Market Size and Forecast, by Country
    • 16.5.12 Brazil
      • 16.5.9.1 Brazil Market Size and Forecast, by Type
      • 16.5.9.2 Brazil Market Size and Forecast, by Product
      • 16.5.9.3 Brazil Market Size and Forecast, by Application
      • 16.5.9.4 Brazil Market Size and Forecast, by Technology
      • 16.5.9.5 Brazil Market Size and Forecast, by End User
      • 16.5.9.6 Brazil Market Size and Forecast, by Process
      • 16.5.9.7 Brazil Market Size and Forecast, by Component
      • 16.5.9.8 Brazil Market Size and Forecast, by Stage
      • 16.5.9.9 Brazil Market Size and Forecast, by Functionality
      • 16.5.9.10 Local Competition Analysis
      • 16.5.9.11 Local Market Analysis
    • 16.5.1 Mexico
      • 16.5.10.1 Mexico Market Size and Forecast, by Type
      • 16.5.10.2 Mexico Market Size and Forecast, by Product
      • 16.5.10.3 Mexico Market Size and Forecast, by Application
      • 16.5.10.4 Mexico Market Size and Forecast, by Technology
      • 16.5.10.5 Mexico Market Size and Forecast, by End User
      • 16.5.10.6 Mexico Market Size and Forecast, by Process
      • 16.5.10.7 Mexico Market Size and Forecast, by Component
      • 16.5.10.8 Mexico Market Size and Forecast, by Stage
      • 16.5.10.9 Mexico Market Size and Forecast, by Functionality
      • 16.5.10.10 Local Competition Analysis
      • 16.5.10.11 Local Market Analysis
    • 16.5.1 Argentina
      • 16.5.11.1 Argentina Market Size and Forecast, by Type
      • 16.5.11.2 Argentina Market Size and Forecast, by Product
      • 16.5.11.3 Argentina Market Size and Forecast, by Application
      • 16.5.11.4 Argentina Market Size and Forecast, by Technology
      • 16.5.11.5 Argentina Market Size and Forecast, by End User
      • 16.5.11.6 Argentina Market Size and Forecast, by Process
      • 16.5.11.7 Argentina Market Size and Forecast, by Component
      • 16.5.11.8 Argentina Market Size and Forecast, by Stage
      • 16.5.11.9 Argentina Market Size and Forecast, by Functionality
      • 16.5.11.10 Local Competition Analysis
      • 16.5.11.11 Local Market Analysis
    • 16.5.1 Rest of Latin America
      • 16.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 16.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 16.5.12.3 Rest of Latin America Market Size and Forecast, by Application
      • 16.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
      • 16.5.12.5 Rest of Latin America Market Size and Forecast, by End User
      • 16.5.12.6 Rest of Latin America Market Size and Forecast, by Process
      • 16.5.12.7 Rest of Latin America Market Size and Forecast, by Component
      • 16.5.12.8 Rest of Latin America Market Size and Forecast, by Stage
      • 16.5.12.9 Rest of Latin America Market Size and Forecast, by Functionality
      • 16.5.12.10 Local Competition Analysis
      • 16.5.12.11 Local Market Analysis
  • 16.1 Middle East and Africa
    • 16.6.1 Key Market Trends and Opportunities
    • 16.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 16.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 16.6.4 Middle East and Africa Market Size and Forecast, by Application
    • 16.6.5 Middle East and Africa Market Size and Forecast, by Technology
    • 16.6.6 Middle East and Africa Market Size and Forecast, by End User
    • 16.6.7 Middle East and Africa Market Size and Forecast, by Process
    • 16.6.8 Middle East and Africa Market Size and Forecast, by Component
    • 16.6.9 Middle East and Africa Market Size and Forecast, by Stage
    • 16.6.10 Middle East and Africa Market Size and Forecast, by Functionality
    • 16.6.11 Middle East and Africa Market Size and Forecast, by Country
    • 16.6.12 Saudi Arabia
      • 16.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 16.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 16.6.9.3 Saudi Arabia Market Size and Forecast, by Application
      • 16.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
      • 16.6.9.5 Saudi Arabia Market Size and Forecast, by End User
      • 16.6.9.6 Saudi Arabia Market Size and Forecast, by Process
      • 16.6.9.7 Saudi Arabia Market Size and Forecast, by Component
      • 16.6.9.8 Saudi Arabia Market Size and Forecast, by Stage
      • 16.6.9.9 Saudi Arabia Market Size and Forecast, by Functionality
      • 16.6.9.10 Local Competition Analysis
      • 16.6.9.11 Local Market Analysis
    • 16.6.1 UAE
      • 16.6.10.1 UAE Market Size and Forecast, by Type
      • 16.6.10.2 UAE Market Size and Forecast, by Product
      • 16.6.10.3 UAE Market Size and Forecast, by Application
      • 16.6.10.4 UAE Market Size and Forecast, by Technology
      • 16.6.10.5 UAE Market Size and Forecast, by End User
      • 16.6.10.6 UAE Market Size and Forecast, by Process
      • 16.6.10.7 UAE Market Size and Forecast, by Component
      • 16.6.10.8 UAE Market Size and Forecast, by Stage
      • 16.6.10.9 UAE Market Size and Forecast, by Functionality
      • 16.6.10.10 Local Competition Analysis
      • 16.6.10.11 Local Market Analysis
    • 16.6.1 South Africa
      • 16.6.11.1 South Africa Market Size and Forecast, by Type
      • 16.6.11.2 South Africa Market Size and Forecast, by Product
      • 16.6.11.3 South Africa Market Size and Forecast, by Application
      • 16.6.11.4 South Africa Market Size and Forecast, by Technology
      • 16.6.11.5 South Africa Market Size and Forecast, by End User
      • 16.6.11.6 South Africa Market Size and Forecast, by Process
      • 16.6.11.7 South Africa Market Size and Forecast, by Component
      • 16.6.11.8 South Africa Market Size and Forecast, by Stage
      • 16.6.11.9 South Africa Market Size and Forecast, by Functionality
      • 16.6.11.10 Local Competition Analysis
      • 16.6.11.11 Local Market Analysis
    • 16.6.1 Rest of MEA
      • 16.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 16.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 16.6.12.3 Rest of MEA Market Size and Forecast, by Application
      • 16.6.12.4 Rest of MEA Market Size and Forecast, by Technology
      • 16.6.12.5 Rest of MEA Market Size and Forecast, by End User
      • 16.6.12.6 Rest of MEA Market Size and Forecast, by Process
      • 16.6.12.7 Rest of MEA Market Size and Forecast, by Component
      • 16.6.12.8 Rest of MEA Market Size and Forecast, by Stage
      • 16.6.12.9 Rest of MEA Market Size and Forecast, by Functionality
      • 16.6.12.10 Local Competition Analysis
      • 16.6.12.11 Local Market Analysis

17: Competitive Landscape

  • 17.1 Overview
  • 17.2 Market Share Analysis
  • 17.3 Key Player Positioning
  • 17.4 Competitive Leadership Mapping
    • 17.4.1 Star Players
    • 17.4.2 Innovators
    • 17.4.3 Emerging Players
  • 17.5 Vendor Benchmarking
  • 17.6 Developmental Strategy Benchmarking
    • 17.6.1 New Product Developments
    • 17.6.2 Product Launches
    • 17.6.3 Business Expansions
    • 17.6.4 Partnerships, Joint Ventures, and Collaborations
    • 17.6.5 Mergers and Acquisitions

18: Company Profiles

  • 18.1 Seppic
    • 18.1.1 Company Overview
    • 18.1.2 Company Snapshot
    • 18.1.3 Business Segments
    • 18.1.4 Business Performance
    • 18.1.5 Product Offerings
    • 18.1.6 Key Developmental Strategies
    • 18.1.7 SWOT Analysis
  • 18.2 Croda International
    • 18.2.1 Company Overview
    • 18.2.2 Company Snapshot
    • 18.2.3 Business Segments
    • 18.2.4 Business Performance
    • 18.2.5 Product Offerings
    • 18.2.6 Key Developmental Strategies
    • 18.2.7 SWOT Analysis
  • 18.3 Avanti Polar Lipids
    • 18.3.1 Company Overview
    • 18.3.2 Company Snapshot
    • 18.3.3 Business Segments
    • 18.3.4 Business Performance
    • 18.3.5 Product Offerings
    • 18.3.6 Key Developmental Strategies
    • 18.3.7 SWOT Analysis
  • 18.4 Aphios Corporation
    • 18.4.1 Company Overview
    • 18.4.2 Company Snapshot
    • 18.4.3 Business Segments
    • 18.4.4 Business Performance
    • 18.4.5 Product Offerings
    • 18.4.6 Key Developmental Strategies
    • 18.4.7 SWOT Analysis
  • 18.5 Vaxine Pty Ltd
    • 18.5.1 Company Overview
    • 18.5.2 Company Snapshot
    • 18.5.3 Business Segments
    • 18.5.4 Business Performance
    • 18.5.5 Product Offerings
    • 18.5.6 Key Developmental Strategies
    • 18.5.7 SWOT Analysis
  • 18.6 Brenntag Biosector
    • 18.6.1 Company Overview
    • 18.6.2 Company Snapshot
    • 18.6.3 Business Segments
    • 18.6.4 Business Performance
    • 18.6.5 Product Offerings
    • 18.6.6 Key Developmental Strategies
    • 18.6.7 SWOT Analysis
  • 18.7 Adjuvatis
    • 18.7.1 Company Overview
    • 18.7.2 Company Snapshot
    • 18.7.3 Business Segments
    • 18.7.4 Business Performance
    • 18.7.5 Product Offerings
    • 18.7.6 Key Developmental Strategies
    • 18.7.7 SWOT Analysis
  • 18.8 MVP Laboratories
    • 18.8.1 Company Overview
    • 18.8.2 Company Snapshot
    • 18.8.3 Business Segments
    • 18.8.4 Business Performance
    • 18.8.5 Product Offerings
    • 18.8.6 Key Developmental Strategies
    • 18.8.7 SWOT Analysis
  • 18.9 Creative Biolabs
    • 18.9.1 Company Overview
    • 18.9.2 Company Snapshot
    • 18.9.3 Business Segments
    • 18.9.4 Business Performance
    • 18.9.5 Product Offerings
    • 18.9.6 Key Developmental Strategies
    • 18.9.7 SWOT Analysis
  • 18.10 OZ Biosciences
    • 18.10.1 Company Overview
    • 18.10.2 Company Snapshot
    • 18.10.3 Business Segments
    • 18.10.4 Business Performance
    • 18.10.5 Product Offerings
    • 18.10.6 Key Developmental Strategies
    • 18.10.7 SWOT Analysis
  • 18.11 InvivoGen
    • 18.11.1 Company Overview
    • 18.11.2 Company Snapshot
    • 18.11.3 Business Segments
    • 18.11.4 Business Performance
    • 18.11.5 Product Offerings
    • 18.11.6 Key Developmental Strategies
    • 18.11.7 SWOT Analysis
  • 18.12 GSK Vaccines Institute for Global Health
    • 18.12.1 Company Overview
    • 18.12.2 Company Snapshot
    • 18.12.3 Business Segments
    • 18.12.4 Business Performance
    • 18.12.5 Product Offerings
    • 18.12.6 Key Developmental Strategies
    • 18.12.7 SWOT Analysis
  • 18.13 Dynavax Technologies
    • 18.13.1 Company Overview
    • 18.13.2 Company Snapshot
    • 18.13.3 Business Segments
    • 18.13.4 Business Performance
    • 18.13.5 Product Offerings
    • 18.13.6 Key Developmental Strategies
    • 18.13.7 SWOT Analysis
  • 18.14 Novavax
    • 18.14.1 Company Overview
    • 18.14.2 Company Snapshot
    • 18.14.3 Business Segments
    • 18.14.4 Business Performance
    • 18.14.5 Product Offerings
    • 18.14.6 Key Developmental Strategies
    • 18.14.7 SWOT Analysis
  • 18.15 EpiVax
    • 18.15.1 Company Overview
    • 18.15.2 Company Snapshot
    • 18.15.3 Business Segments
    • 18.15.4 Business Performance
    • 18.15.5 Product Offerings
    • 18.15.6 Key Developmental Strategies
    • 18.15.7 SWOT Analysis
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제